Where MCT powder is permitted, and what the file must show
MCT oil is a food ingredient with a long history of use, and a 50% microencapsulated powder can be sold as an ingredient for food supplements in the EU, the US and the UK. Permission is rarely the obstacle. The file is the obstacle: the source oil and its allergen position, the legal status of the modified starch carrier, the contaminant data, the label declaration and the absence of a disease claim. The three markets do not ask for the same file, and the UK has to be checked separately from the EU.
MCT powder is permitted in all three markets; the source declaration, the carrier's status and the claim wording are what decide whether the file supports the label.
Three markets, three instruments
The EU regulates the powder under food law and, when it is sold in dose form, under the food supplements directive. The US regulates a supplement under DSHEA and the current good manufacturing practice rules for dietary supplements. The UK applies retained EU law in Great Britain, with Northern Ireland following the EU regime. In each market the ingredient status and the finished-product status are separate questions, and the label rules follow the finished product.
In Great Britain, the food supplements regulations and the retained nutrition and health claims rules apply; Northern Ireland follows the EU texts. A GB label and an NI label can therefore diverge on claims and on some labelling details, so a product sold across the UK needs both checked.
The statements here are a summary as of this review. Contaminant limits, labelling guidance and claim lists change; check the current text before a launch.
European Union
MCT oil is used as a food ingredient and has a history of use before the novel food cut-off, so the oil itself does not need a novel food authorisation. The powder is not automatically covered by that history: the carrier, any antioxidant and the microencapsulation process have to be assessed on their own. Modified starch must be an authorised additive or a permitted ingredient for the intended use, and the specification should name the type, not only “modified starch.”
For a supplement, Directive 2002/46/EC sets the framework; Regulation 1169/2011 governs the label; Regulation 1924/2006 governs claims; Regulation 2023/915 sets contaminant limits; Regulation 2015/2283 governs novel foods. The source oil matters for the allergen file: coconut and palm kernel are not on the EU Annex II list. That does not remove the need for a source statement, and it does not cover a carrier or a processing aid that carries its own allergen.
United States
A dietary supplement is regulated under DSHEA, with cGMP in 21 CFR 111 and labelling in 21 CFR 101. The ingredient statement, the Supplement Facts panel and the allergen statement are the three label elements that most often decide a launch. Coconut is classified as a tree nut for US labelling; a highly refined oil derived from coconut may fall within the refined-oil exemption, but the supplier has to document the basis rather than leave the buyer to assume it.
Structure/function claims are permitted for a supplement with the required disclaimer and must be truthful and not misleading. A disease claim is not permitted. The line between the two is a labelling question, not a formulation question, and it should be reviewed before the artwork is final.
Contaminants and the limits that matter
The catalog panel is a release gate, not a statement of every legal limit. The limit that applies depends on whether the powder is sold as a food supplement or used as an ingredient in a conventional food, and on the market.
| Parameter | Catalog limit | What to check |
|---|---|---|
| Lead | ≤3 mg/kg | Finished-product limit for the market and category |
| Arsenic | ≤2 mg/kg | Market-specific limit or customer specification |
| Cadmium | ≤1 mg/kg | Finished-product limit for the market and category |
| Mercury | ≤0.1 mg/kg | Finished-product limit for the market and category |
| Microbiology | APC ≤1,000 cfu/g; yeast and mould ≤100 cfu/g; E. coli and Salmonella absent | Finished-product specification and market guidance |
| Peroxide value | ≤1.0 meq/kg | Shelf-life headroom, not only release |
For a refined oil, also ask for the process-contaminant data the market requires, such as 3-MCPD and glycidyl esters, and for the PAH panel where the oil source makes it relevant. These are not lines on the catalog COA; they are questions for the supplier's food-safety file.
Where the claim line sits
The defensible statements about this powder are compositional: the oil load, the C8/C10 profile, the carrier, the fat content and the physical form. Those statements can be checked against the COA and the specification. A statement about what the powder does in the body is a different category, and it needs the evidence and the wording that the market allows.
On the nutrition panel, the oil contributes fat and saturated fat; the modified starch contributes carbohydrate. The C8/C10 split is not a separate nutrition line in the EU or the US; it belongs in the ingredient description or the specification. Avoid turning the ratio into an implied health claim. The label should describe the material, not promise an outcome.
The file a buyer should hold
A market-ready file usually contains: the specification, the batch COA, the technical data sheet, the safety data sheet, the allergen and source statement, the carrier declaration, the heavy-metal and microbiology results, the shelf-life statement and the storage condition, a manufacturing flow chart and the lot traceability record. Add a GMO statement, a halal or kosher certificate or a country-of-origin declaration only where the market or the customer asks for it.
The file should be internally consistent. The oil load on the COA, the TDS and the label should be the same figure. The carrier named on the TDS should be the carrier in the allergen and additive review. The lot code on the COA should match the pack and the retained sample. Inconsistency is a common reason a file fails a customer audit, not a missing document.
A launch checklist
- Confirm the market and whether the product is a supplement or a conventional food.
- Name the oil source and check the allergen position for that source.
- Name the modified starch and confirm its additive or ingredient status.
- Check the contaminant limits against the finished product, not only the powder.
- Check the nutrition declaration and the ingredient name.
- Review every claim against the permitted list and the evidence.
- Match the lot code across COA, pack and retained sample.
- File the TDS, SDS, COA, allergen statement and shelf-life data together.
The COA page explains the certificate lines; the MOQ page covers the order file; the identity page covers the C8/C10 evidence. The market summaries are on the EU, US and UK pages, and the quality page describes the release route.
Related documents
Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.
Request a quotation